Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch

Nature Genetics

Volumn 38, Issue 11, 2006, Pages 1329-1334

  Richardson, Rebecca J ^a,b   Dixon, Jill ^b   Malhotra, Saimon ^a,b   Hardman, Matthew J ^a   Knowles, Lynnette ^a   Boot Handford, Ray P ^a   Shore, Paul ^a   Whitmarsh, Alan ^a   Dixon, Michael J ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 6; PROTEIN STRATIFIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; GENE MUTATION; HOMOZYGOSITY; KERATINOCYTE; MISSENSE MUTATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKIN DEFECT; VAN DER WOUDE SYNDROME; WEBBED NECK;

14-3-3 PROTEINS; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CLEFT PALATE; EPIDERMIS; FEMALE; GENES, SWITCH; HUMANS; I-KAPPA B KINASE; INTERFERON REGULATORY FACTORS; KERATINOCYTES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOUTH ABNORMALITIES; MUTATION, MISSENSE; PREGNANCY;

EID: 33750441851     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1894     Document Type: Article

References (28)

1. Fuchs, E. & Raghavan, S. Getting under the skin of epidermal morphogenesis. Nat. Rev. Genet. 3, 199-209 (2002).
2. Watt, F.M. Stem cell fate and patterning in mammalian epidermis. Curr. Opin. Genet. Dev. 11, 410-417 (2001).
3. Dotto, G.P. Signal transduction pathways controlling the switch between keratinocyte growth and differentiation. Crit. Rev. Oral Biol. Med. 10, 442-457 (1999).
4. Taniguchi, T., Ogasawara, K., Takaoka, A. & Tanaka, N. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19, 623-655 (2001).
5. Kondo, S. et al. Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat. Genet. 32, 285-289 (2002).
6. Escalante, C.R., Yie, J., Thanos, D. & Aggarwal, A.K. Structure of IRF-1 with bound DNA reveals determinants of interferon regulation. Nature 391, 103-106 (1998).
7. Hardman, M.J., Sisi, P., Banbury, D.N. & Byrne, C. Patterned acquisition of skin barrier function during development. Development 125, 1541-1552 (1998).
8. Benitah, S.A., Frye, M., Glogauer, M. & Watt, F.M. Stem cell depletion through epidermal deletion of Rac1. Science 309, 933-935 (2005).
9. Guenet, J.L., Salzgeber, B. & Tassin, M.T. Repeated epilation: a genetic epidermal syndrome in mice. J. Hered. 70, 90-94 (1979).
10. Herron, B.J. et al. A mutation in stratifin is responsible for the repeated epilation (Er) phenotype in mice. Nat. Genet. 37, 1210-1212 (2005).
11. Li, Q., Lu, Q., Estepa, G. & Verma, I.M. Identification of 14-3-3sigma mutation causing cutaneous abnormality in repeated-epilation mutant mouse. Proc. Natl. Acad. Sci. USA 102, 15977-15982 (2005).
12. Takeda, K. et al. Limb and skin abnormalities in mice lacking IKKalpha. Science 284, 313-316 (1999).
13. Hu, Y. et al. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 284, 316-320 (1999).
14. Li, Q. et al. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13, 1322-1328 (1999).
15. Pellegrini, G. et al. p63 identifies keratinocyte stem cells. Proc. Natl. Acad. Sci. USA 98, 3156-3161 (2001).
16. Hermeking, H. et al. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1, 3-11 (1997).
17. Chan, T.A., Hermeking, H., Lengauer, C., Kinzler, K.W. & Vogelstein, B. 14-3-3sigma is required to prevent mitotic catastrophe after DNA damage. Nature 401, 616-620 (1999).
18. Lees, M.M., Winter, R.M., Malcolm, S., Saal, H.M. & Chitty, L. Popliteal pterygium syndrome: a clinical study of three families and report of linkage to the Van der Woude syndrome locus on 1q32. J. Med. Genet. 36, 888-892 (1999).
19. Dixon, J. et al. Tcof1/Treacle is required for neural crest stem cell formation and proliferation through its role in mature ribosome production, deficiencies in which cause craniofacial abnormalities. Proc. Natl. Acad. Sci. USA 103, 13403-13408 (2006).
20. Ghassibe, M. et al. Six families with Van der Woude and/or popliteal pterygium syndrome: all with a mutation in the IRF6 gene. J. Med. Genet. 41, e15 (2004).
21. Ingraham, C.R. et al. Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6). Nat. Genet. advance online publication 15 October 2006 (doi:10.1038/ng1903).
22. Mills, A.A. et al. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398, 708-713 (1999).
23. Yang, A. et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398, 714-718 (1999).
24. Koster, M.I., Kim, S., Mills, A.A., DeMayo, F.J. & Roop, D.R. p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev. 18, 126-131 (2004).
25. Sil, A.K., Maeda, S., Sano, Y., Roop, D.R. & Karin, M. IkB Kinase-α acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature 428, 660-664 (2004).
26. Wallin, J. et al. The role of Pax-1 in axial skeleton development. Development 120, 1109-1121 (1994).
27. Mooney, L.M. & Whitmarsh, A.J. Docking interactions in the c-Jun N-terminal pathway. J. Biol. Chem. 279, 11843-11852 (2004).
28. Inman, C.K., Li, N. & Shore, P. Oct-1 counteracts autoinhibition of Runx2 DNA binding to form a novel Runx2/Oct-1 complex on the promoter of the mammary gland-specific gene β-casein. Mol. Cell. Biol. 25, 3182-3193 (2005).